Jude A. Oben

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Medicine, Internal Medicine, Pharmacology +8

Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study

Andrea Dennis, Małgorzata Wamil, Johann Alberts et al. · BMJ Open · 2021 · 581 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17

Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice

Jude A. Oben, Angelina Mouralidarane, Anne‐Maj Samuelsson et al. · Journal of Hepatology · 2010 · 326 citations

Medicine, Developmental Biology, Obstetrics +16

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

Akira Hirose, Masafumi Ono, Toshiji Saibara et al. · Hepatology · 2007 · 233 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Hepatic fibrogenesis requires sympathetic neurotransmitters

Jude A. Oben · Gut · 2004 · 220 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17